CN108523137A - A kind of preparation method of the probiotic granulate of acid and bile salt tolerance - Google Patents
A kind of preparation method of the probiotic granulate of acid and bile salt tolerance Download PDFInfo
- Publication number
- CN108523137A CN108523137A CN201810354767.2A CN201810354767A CN108523137A CN 108523137 A CN108523137 A CN 108523137A CN 201810354767 A CN201810354767 A CN 201810354767A CN 108523137 A CN108523137 A CN 108523137A
- Authority
- CN
- China
- Prior art keywords
- acid
- preparation
- lactobacillus
- mixed
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 56
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 56
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 39
- 239000008187 granular material Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 239000002253 acid Substances 0.000 title claims abstract description 20
- 239000003833 bile salt Substances 0.000 title claims abstract description 16
- 230000015784 hyperosmotic salinity response Effects 0.000 title claims abstract description 16
- 239000000243 solution Substances 0.000 claims abstract description 24
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 13
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000003223 protective agent Substances 0.000 claims abstract description 11
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 11
- 239000000661 sodium alginate Substances 0.000 claims abstract description 11
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000839 emulsion Substances 0.000 claims abstract description 10
- 238000005453 pelletization Methods 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 8
- 239000002002 slurry Substances 0.000 claims abstract description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 6
- 238000004132 cross linking Methods 0.000 claims abstract description 6
- 239000007787 solid Substances 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 235000011187 glycerol Nutrition 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000013019 agitation Methods 0.000 claims abstract description 4
- 238000002347 injection Methods 0.000 claims abstract description 4
- 239000007924 injection Substances 0.000 claims abstract description 4
- 235000020985 whole grains Nutrition 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 11
- 235000020183 skimmed milk Nutrition 0.000 claims description 9
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 239000011814 protection agent Substances 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241000186660 Lactobacillus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 210000000941 bile Anatomy 0.000 claims description 3
- 239000000084 colloidal system Substances 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 229940039696 lactobacillus Drugs 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 2
- 241000186012 Bifidobacterium breve Species 0.000 claims description 2
- 241001608472 Bifidobacterium longum Species 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 241000186840 Lactobacillus fermentum Species 0.000 claims description 2
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 2
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 2
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 2
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 2
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 2
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- 240000002605 Lactobacillus helveticus Species 0.000 claims 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 claims 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims 1
- 238000005238 degreasing Methods 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 229940054346 lactobacillus helveticus Drugs 0.000 claims 1
- 229940099352 cholate Drugs 0.000 abstract description 5
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000002245 particle Substances 0.000 description 27
- 230000000968 intestinal effect Effects 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000036632 reaction speed Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/123—Bulgaricus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/145—Gasseri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/181—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to field of probiotic bacteria more particularly to a kind of preparation methods of the probiotic granulate of acid and bile salt tolerance.Include the following steps:S1, probiotics bacterium mud is uniformly mixed with protective agent, is slowly stirred to form emulsion;S2, emulsion and colloidal solution are added to the colloidal solution configured after mixing, stirring makes it be uniformly mixed, is slowly stirred to form mixed liquor;S3, it mixed liquor is slowly injected into calcium chloride solution carries out cross-linking reaction, high shear agitation is carried out after the injection of whole mixed liquors, be then allowed to stand to obtain Mixed Microbes slurry;S4, Mixed Microbes slurry is obtained into the solid that water content is less than 5% by freeze-drying, is crushed whole grain using crushing and pelletizing machine and obtains the probiotic granulate of 20 50 mesh;Protective agent includes trehalose, glycerine and converted starch, and colloidal solution includes sodium alginate;The probiotic granulate that the preparation method of the present invention obtains reaches the holding activity that enteron aisle can be largely to sour and cholate with good tolerability, by stomach.
Description
Technical field
The present invention relates to field of probiotic bacteria more particularly to a kind of preparation methods of the probiotic granulate of acid and bile salt tolerance.
Background technology
Probiotics is a kind of bacterium that facilitation can be played to health, common probiotics include Bacillus acidi lactici,
Bifidobacterium and streptococcus etc..For example, Bacillus acidi lactici is mainly colonized in human small intestine, it is big that Bifidobacterium is mainly colonized in human body
If enteral can play the role of comprehensive adjustment using the strain of compounding to human body.The organic acid of these probiotics metabolism generation,
Polysaccharide, bacteriocin and special enzyme system etc. have to human body adjust stomach colony balance, improve immunity, anti-aging, improve constipation,
Diarrhea and allergic symptom and other effects.
Modern humans' living standard rises, and the pollution of environment, abuse of drug etc. are to the microecological balance of human body and immune
Power causes many negative effects, and the crowd in inferior health is also increasing.And targetedly the edible food containing probiotics can
To adjust the balance of human internal environment, autoimmunity is improved.
Currently, probiotics preparation is mostly deposited in the form of pulvis, tablet, hard capsule, granule etc. in food and field of health care products
By the control of packaging material and environmental condition, further requirement could reached in product viable count stability, and in mouth
It is easily interfered by stress such as alimentary canal, gastric juice, cholate during clothes, is easy to lose activity before entering small intestine, losing it should have
Probiotic effects, cause it is practical fail to reach requirement in host intestine release action amount, so needing in product forms and preparation
Process orientation is studied, and discussion can resist host's gastric juice, cholate stress, carry out the prebiotic becteriums product shape of enteron aisle controlled release
Formula.
Invention content
There is good tolerability to acid and cholate, leads in order to solve the above technical problems, the object of the present invention is to provide one kind
Cross the benefit that stomach reaches active, beneficial function to ensure probiotics the acid and bile salt tolerance of the holding that enteron aisle can be largely
The preparation method of raw bacterium particle.
The present invention provides a kind of preparation method of the probiotic granulate of aforementioned acid and bile salt tolerance, includes the following steps:
S1, by probiotics bacterium mud and protective agent with 1:4 to 4:1 ratio is uniformly mixed, and is slowly stirred 10-40min and is formed
Emulsion;
S2, by emulsion and colloidal solution with 1:2 to 8:The colloidal solution configured is added in 1 ratio, and stirring keeps its mixing equal
It is even, it is slowly stirred 5-10min, forms mixed liquor;
S3, the calcium chloride solution that 0.25 to 1 times of the mass concentration that mixed liquor is slowly injected into its quality is 0.2%-5%
Middle carry out cross-linking reaction carries out high shear agitation 2-10min after the injection of whole mixed liquors, is then allowed to stand 5-20min, obtains
Mixed Microbes are starched;
S4, by Mixed Microbes slurry by freeze-drying obtain water content be less than 5% solid, using crushing and pelletizing machine by its into
Row crushing and pelletizing obtains the probiotic granulate of 20-50 mesh;
Wherein, the protective agent includes trehalose, glycerine and converted starch, and the colloidal solution includes sodium alginate.
It should be noted that the sodium alginate in colloidal solution, which crosslinks to react with calcium chloride, can form macromolecular polymeric
Cohesion occurs in low ph conditions (such as gastric juice) for object, the polymer, protects probiotic granulate non-inactivation, and in higher pH rings
It is disintegrated in border (such as intestinal juice), discharges probiotic granulate therein.Protective agent then can effectively protect probiotics in higher pH rings
It is not inactivated by cholate in border (such as intestinal juice), finally to promote probiotics in intestinal colonisation.
It should be noted that in step S1, probiotics bacterium mud and protectant mixed proportion, protectant ingredient and
The time is mixed, it will influence bacterium amount yield, the acid and bile salt tolerance of the obtained probiotic granulate of preparation method of the present invention
Performance, specific detailed in Example.
It should be noted that in step S2, the mixed proportion of emulsion and colloidal solution, it will influence probiotic granulate and exist
Embedding effect in the macromolecule polyalcohol that sodium alginate and calcium chloride are cross-linked to form will cause when colloid liquid hold-up is too small
It is bad to embed effect, when colloid liquid hold-up is excessive, bacterium amount yield will be caused relatively low and the waste of embedded material.
It should be noted that step S3 in, the mixed proportion and calcium chloride solution of mixed liquor and calcium chloride solution it is dense
Degree, it will polymer physicochemical property, reaction speed and the intensity for influencing embedded material after cross-linking reaction, when calcium chloride solution ratio
When example is higher, reaction speed will be caused too fast, when calcium chloride solution concentration is higher, cross-linking reaction excessive velocities, institute will be caused
It is inhomogenous to obtain Mixed Microbes slurry reaction result.
The patent of invention that Chinese Patent Application No. is 200610010518.9 discloses a kind of beneficial bacteria of intestinal tract embedding protection
Method, however by experimental results demonstrate the microbial bacterial agent Pa after freeze-drying can be redissolved after being mixed into emulsified solution B1, become
Uniform mixture can't form double-layer embedment structure, after being blended into sodium alginate soln, can remix uniformly mixed at one
Close liquid;In addition, the live probiotic bacteria preparation finally obtained in a manner of natural drying, it is also difficult to which industry is realized in mass application
Change.
The patent of invention that Chinese Patent Application No. is 201610881048.7 discloses a kind of probiotic microcapsule and its system
Preparation Method, however, using vegetable oil emulsifying manner, industrialized production also brings inconvenience, is actually also difficult to industrialization.
Further, it includes trehalose 20-50%, glycerine 2-10%, sucrose 2- that agent solution is protected described in step S1
10%, converted starch 2-10%, vitamin 0.1-2%, amino acid 1-8%, skimmed milk powder 2-20%.
Specifically, the colloidal solution includes 5% sodium alginate.
Specifically, the vitamin includes one or more in vitamin B, vitamin C, vitamin D, vitamin E.
Specifically, the skimmed milk powder includes ox skimmed milk powder, sheep skimmed milk powder, one kind in horse skimmed milk powder or more
Kind.
Specifically, the amino acid includes methionine, tyrosine, arginine, cysteine, valine, histidine, bright ammonia
It is one or more in acid, glycine, alanine, glutamic acid, lysine.
Specifically, the probiotics described in step S1 includes lactobacillus plantarum, Lactobacillus casei, lactobacillus acidophilus, sandlwood
Sugared lactobacillus, lactobacillus reuteri, Lactobacillus paracasei, lactobacillus fermenti, lactobacillus gasseri, Yue Shi lactobacillus, Switzerland's breast bar
Bacterium, Lactobacillus salivarius, lactobacillus bulgaricus, bifidobacterium longum, bifidobacterium breve, bifidobacterium lactis, bifidobacterium adolescentis, two
It is one or more in discrimination Bifidobacterium, streptococcus thermophilus.
According to the above aspect of the present invention, the present invention has at least the following advantages:Feed liquid is prepared with sodium alginate mixed active ingredient, so
Gel in calcium chloride solution is instilled afterwards detaches drying after particle, here it is the micro-embedded methods of common enteric at particle.Due to logical
It is larger (being typically larger than 2.5mm) to cross the particle that dripping feed liquid granulating obtains, so developing emulsion process again, for example feed liquid is emulsified
Into vegetable oil, then add calcium chloride solution, the particle of very little will be obtained, as grain size is less than 0.05mm.
Enteric coated particles probiotics uses in industrialization generally as additive, therefore higher to Particle size requirements, such as
Otherwise 0.2-0.5mm cannot be mixed in compounding to end product.So the bulky grain of dropping preparation method production can not just use;So
And emulsion process, as a result of vegetable oil, industrialized production also brings inconvenience, is actually also difficult to industrialization.Therefore, such as
What obtains the smaller probiotic granulate of grain size by relatively simple production technology, becomes the developing direction of probiotics industry.
In the present invention, feed liquid and sodium alginate soln are mixed, are then added in calcium chloride solution, at this time in mixed liquor
The gel piece that will produce bulk can form uniform little particle by uniform to the mixture high speed shear containing gel piece, freeze
20-50 mesh probiotic granulates can be obtained in crushing and pelletizing again after dry.Since the material after high speed shear has been formed substantially in fact
Even little particle gel, although may have in a liquid it is viscous, freeze-drying after again crushing and pelletizing, be easy to get 20-50 purposes
Grain;Crushing and pelletizing is difficult to obtain the little particle of 20-50 mesh after common feed liquid freeze-drying.
In addition, the present invention provides a kind of optimal production technology, reasonably protect agent prescription, work that can be relatively simple
Skill obtains the probiotic granulate of preferable acid and bile salt tolerance, it can be achieved that industrialization.
Above description is only the general introduction of technical solution of the present invention, in order to better understand the technical means of the present invention,
And can be implemented in accordance with the contents of the specification, it is described in detail as after with presently preferred embodiments of the present invention below.
Specific implementation mode
With reference to embodiment, the embodiment of the present invention is furthur described in detail.Following embodiment is used for
Illustrate the present invention, but is not limited to the scope of the present invention.
Embodiment one
The present embodiment provides a kind of preparation method of the probiotic granulate of acid and bile salt tolerance by taking lactobacillus acidophilus as an example, and
It detects that different protective agents are acidproof for probiotic granulate, influence of bile tolerance performance, includes the following steps:
S1, configuration protection agent solution, sterilizing postcooling is for use to room temperature, and substance used meets Food Inspection standard;
The sodium alginate colloidal solution of configuration quality a concentration of 5%, sterilizing postcooling are for use to room temperature;
S2, by lactobacillus acidophilus bacterium mud with protection agent solution with 1:1 ratio is uniformly mixed, and is slowly stirred 30min, is formed
Emulsion;
S3, with 2:Emulsion, is added the colloidal solution configured by 1 ratio, and stirring makes it be uniformly mixed, is slowly stirred
5min forms bacterium glue mixed liquor;
S4, bacterium glue mixed liquor is slowly injected into its quality 0.25 times of mass concentration be 2% calcium chloride solution in into
Row cross-linking reaction carries out high shear agitation 5min after the injection of whole mixed liquors, is then allowed to stand 10min, obtains Mixed Microbes slurry;
S5, by Mixed Microbes slurry by freeze-drying obtain water content be less than 5% solid, using crushing and pelletizing machine by its into
Row crushing and pelletizing obtains the probiotic granulate of 20-50 mesh.
It is specific as shown in table 1 the present embodiment provides three kinds of experiment group of formula for protective agent:
The different protectant formulas of table 1
Correspondingly, using formula 1, being formulated 2 and being formulated 3 and be pulled through the probiotic granulate that above-mentioned test method obtains, respectively
For particle 1, particle 2 and particle 3.
The present embodiment also provides a kind of probiotic granulate of control group, and preparation method includes the following steps:
S1, configuration protective agent solution sterilization are for use, and protective agent solution formula is:It is 20% trehalose, 2% sucrose, 2% sweet
Oil, 2% converted starch.
S2, by lactobacillus acidophilus bacterium mud and the protection agent solution of configuration with 1:1 ratio is uniformly mixed and obtains emulsion, will
Emulsion obtains the solid that water content is less than 5% by freeze-drying, and solid fungus block is crushed to obtain pair by pulverizer
According to a group Freeze-dry Powder of Probioctics.It should be noted that control group freeze-dried powder, due to being lyophilized again without after high speed shear, grain size is difficult
To reach the level of 20-50 mesh, there is a situation where that a large amount of particles are more than 50 mesh.
By aforementioned particles 1, particle 2, particle 3 and control group freeze-dried powder, acidproof and bile tolerance performance evaluation is carried out, specifically such as
Under:
1) acid resistance is studied
Simulated gastric fluid (dilute hydrochloric acid solution of pH=3) is prepared, four kinds of probiotic granulates or freeze-dried powder are placed in, constant temperature is put into
Shaking table, 180r/min vibrates 1h under the conditions of 37 DEG C, and per 20min, sampling weighs dissolving Mass Calculation rate dissolution rate, and calculates bacterium
Body survival rate.
About particle or freeze-dried powder dissolution rate, the results are shown in Table 2, it is seen that particle 1, particle 2 and particle 3 have good
Acid-fast ability does not almost dissolve, which can be effectively protected thalline, is obviously improved to acid-resisting ability.
Dissolution rate comparing result table of the different probiotic granulates of table 2 in simulated gastric fluid
About thalline survival rate, the results are shown in Table 3, it is seen that particle 1, particle 2 and particle 3 even across simulated gastric fluid at
Reason, can also be effectively ensured the survival rate of wherein probiotics.
Thalline survival rate comparing result table after the different probiotic granulates of table 3 are handled in simulated gastric fluid
2) enteric performance study
Simulated intestinal fluid is prepared, 4 kinds of probiotic granulates are placed in intestinal juice, are put into constant-temperature table, 180r/min under the conditions of 37 DEG C
1h is vibrated, sampling calculates thalline survival rate per 20min, and the results are shown in Table 4, it is seen that particle 1, particle 2 and particle 3 are by artificial
Intestinal juice processing, can be effectively ensured the survival rate of wherein probiotics.
Thalline survival rate comparing result table after the different probiotic granulates of table 4 are handled in simulated intestinal fluid
The above is only a preferred embodiment of the present invention, it is not intended to restrict the invention, it is noted that for this skill
For the those of ordinary skill in art field, without departing from the technical principles of the invention, can also make it is several improvement and
Modification, these improvements and modifications also should be regarded as protection scope of the present invention.
Claims (7)
1. a kind of preparation method of the probiotic granulate of acid and bile salt tolerance, it is characterised in that:The present invention provides a kind of aforementioned acidproof
The preparation method of the probiotic granulate of bile tolerance, includes the following steps:
S1, by probiotics bacterium mud and protective agent with 1:4 to 4:1 ratio is uniformly mixed, and is slowly stirred 10-40min and is formed emulsification
Liquid;
S2, by emulsion and colloidal solution with 1:2 to 8:The colloidal solution configured is added in 1 ratio, and stirring makes it be uniformly mixed, and delays
Slow stirring 5-10min, forms mixed liquor;
S3, mixed liquor is slowly injected into its quality 0.25 to 1 times of mass concentration be 0.2%-5% calcium chloride solution in into
Row cross-linking reaction carries out high shear agitation 2-10min after the injection of whole mixed liquors, is then allowed to stand 5-20min, is mixed
Bacterium is starched;
S4, Mixed Microbes slurry is obtained into the solid that water content is less than 5% by freeze-drying, powder is carried out using crushing and pelletizing machine
Broken whole grain obtains the probiotic granulate of 20-50 mesh;
Wherein, the protective agent includes trehalose, glycerine and converted starch, and the colloidal solution includes sodium alginate.
2. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:In step S1
The protection agent solution includes trehalose 20-50%, glycerine 2-10%, sucrose 2-10%, converted starch 2-10%, vitamin
0.1-2%, amino acid 1-8%, skimmed milk powder 2-20%.
3. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:The colloid
Liquid includes 5% sodium alginate.
4. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:The dimension life
Element includes one or more in vitamin B, vitamin C, vitamin D, vitamin E.
5. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:The degreasing
Milk powder includes one or more in ox skimmed milk powder, sheep skimmed milk powder, horse skimmed milk powder.
6. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:The amino
Acid includes methionine, tyrosine, arginine, cysteine, valine, histidine, leucine, glycine, alanine, paddy ammonia
It is one or more in acid, lysine.
7. the preparation method of the probiotic granulate of acid and bile salt tolerance according to claim 1, it is characterised in that:In step S1
The probiotics includes lactobacillus plantarum, Lactobacillus casei, lactobacillus acidophilus, Lactobacillus rhamnosus, lactobacillus reuteri, pair
Lactobacillus casei, lactobacillus fermenti, lactobacillus gasseri, Yue Shi lactobacillus, Lactobacillus helveticus, Lactobacillus salivarius, bulgarian milk
In bacillus, bifidobacterium longum, bifidobacterium breve, bifidobacterium lactis, bifidobacterium adolescentis, bifidobacterium bifidum, streptococcus thermophilus
It is one or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810354767.2A CN108523137A (en) | 2018-04-19 | 2018-04-19 | A kind of preparation method of the probiotic granulate of acid and bile salt tolerance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810354767.2A CN108523137A (en) | 2018-04-19 | 2018-04-19 | A kind of preparation method of the probiotic granulate of acid and bile salt tolerance |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108523137A true CN108523137A (en) | 2018-09-14 |
Family
ID=63478512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810354767.2A Pending CN108523137A (en) | 2018-04-19 | 2018-04-19 | A kind of preparation method of the probiotic granulate of acid and bile salt tolerance |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108523137A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109105900A (en) * | 2018-11-13 | 2019-01-01 | 丁传波 | A kind of preparation method of novel preserved sliced fresh ginseng |
CN109430500A (en) * | 2018-11-13 | 2019-03-08 | 丁传波 | A kind of preparation method of novel fresh American Ginseng honey piece |
CN109463516A (en) * | 2018-11-13 | 2019-03-15 | 丁传波 | A kind of preparation method of novel red ginseng honey slice |
CN109464613A (en) * | 2019-01-04 | 2019-03-15 | 安发(福建)生物科技有限公司 | A kind of water-solubility function red yeast rice slow-releasing microcapsule and preparation method thereof |
CN109619593A (en) * | 2018-11-08 | 2019-04-16 | 淮阴工学院 | A kind of probiotic double layer microcapsules and preparation method thereof |
CN110731510A (en) * | 2019-11-13 | 2020-01-31 | 苗振伟 | formula for improving activity of probiotic strains and preparation method thereof |
CN111317140A (en) * | 2020-05-06 | 2020-06-23 | 永安康健药业(武汉)有限公司 | Bile salt-resistant and gastric acid-resistant probiotic preparation as well as preparation method and application thereof |
CN111840343A (en) * | 2020-08-18 | 2020-10-30 | 成都蜜儿堂职业技能培训学校有限公司 | Oyster powder for promoting human microcirculation and preparation method thereof |
CN113088474A (en) * | 2021-05-13 | 2021-07-09 | 河北一然生物科技有限公司 | Microbial combined leavening agent and preparation method and application thereof |
CN113100290A (en) * | 2021-05-24 | 2021-07-13 | 宁波大学 | Compound fermentation bacterium agent and application thereof in preparing fermented milk |
CN113528419A (en) * | 2021-07-13 | 2021-10-22 | 镇江市天益生物科技有限公司 | Additive for improving activity of lactobacillus strain and preparation method thereof |
CN114651985A (en) * | 2022-04-12 | 2022-06-24 | 广州市沐家健康产业有限公司 | Probiotic powder with weight-losing effect and preparation method thereof |
-
2018
- 2018-04-19 CN CN201810354767.2A patent/CN108523137A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109619593A (en) * | 2018-11-08 | 2019-04-16 | 淮阴工学院 | A kind of probiotic double layer microcapsules and preparation method thereof |
CN109105900A (en) * | 2018-11-13 | 2019-01-01 | 丁传波 | A kind of preparation method of novel preserved sliced fresh ginseng |
CN109430500A (en) * | 2018-11-13 | 2019-03-08 | 丁传波 | A kind of preparation method of novel fresh American Ginseng honey piece |
CN109463516A (en) * | 2018-11-13 | 2019-03-15 | 丁传波 | A kind of preparation method of novel red ginseng honey slice |
CN109464613A (en) * | 2019-01-04 | 2019-03-15 | 安发(福建)生物科技有限公司 | A kind of water-solubility function red yeast rice slow-releasing microcapsule and preparation method thereof |
CN110731510A (en) * | 2019-11-13 | 2020-01-31 | 苗振伟 | formula for improving activity of probiotic strains and preparation method thereof |
CN111317140A (en) * | 2020-05-06 | 2020-06-23 | 永安康健药业(武汉)有限公司 | Bile salt-resistant and gastric acid-resistant probiotic preparation as well as preparation method and application thereof |
CN111840343A (en) * | 2020-08-18 | 2020-10-30 | 成都蜜儿堂职业技能培训学校有限公司 | Oyster powder for promoting human microcirculation and preparation method thereof |
CN113088474A (en) * | 2021-05-13 | 2021-07-09 | 河北一然生物科技有限公司 | Microbial combined leavening agent and preparation method and application thereof |
CN113088474B (en) * | 2021-05-13 | 2022-03-04 | 河北一然生物科技股份有限公司 | Microbial combined leavening agent and preparation method and application thereof |
CN113100290A (en) * | 2021-05-24 | 2021-07-13 | 宁波大学 | Compound fermentation bacterium agent and application thereof in preparing fermented milk |
CN113528419A (en) * | 2021-07-13 | 2021-10-22 | 镇江市天益生物科技有限公司 | Additive for improving activity of lactobacillus strain and preparation method thereof |
CN114651985A (en) * | 2022-04-12 | 2022-06-24 | 广州市沐家健康产业有限公司 | Probiotic powder with weight-losing effect and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108523137A (en) | A kind of preparation method of the probiotic granulate of acid and bile salt tolerance | |
Liu et al. | Improved survival of Lactobacillus zeae LB1 in a spray dried alginate-protein matrix | |
Islam et al. | Microencapsulation of live probiotic bacteria | |
DK1667696T3 (en) | PROBIOTIC STORAGE AND SUBMISSION | |
Soukoulis et al. | Stability of Lactobacillus rhamnosus GG in prebiotic edible films | |
JP6240386B2 (en) | Probiotic stabilization | |
AU2012210575B2 (en) | Protection of microbial cells from acidic degradation | |
Huang et al. | Microencapsulation of probiotic lactobacilli with shellac as moisture barrier and to allow controlled release | |
Würth et al. | Protective effect of milk protein based microencapsulation on bacterial survival in simulated gastric juice versus the murine gastrointestinal system | |
US20140255366A1 (en) | Novel compositions | |
AU2012210575A1 (en) | Protection of microbial cells from acidic degradation | |
Chun et al. | Microencapsulation of Lactobacillus plantarum DKL 109 using external ionic gelation method | |
ÜNAL et al. | Design of probiotic dry fermented sausage (sucuk) production withmicroencapsulated and free cells of Lactobacillus rhamnosus | |
Duongthingoc et al. | Studies on the viability of Saccharomyces boulardii within microcapsules in relation to the thermomechanical properties of whey protein | |
CN110193029B (en) | Colon-targeted drug delivery method of probiotics | |
Kailasapathy | Microencapsulation for gastrointestinal delivery of probiotic bacteria | |
Khalil et al. | Encapsulation of bifidobacterium pseudocatenulatum strain G4 within bovine gelatin-genipin-sodium alginate combinations: Optimisation approach using face central composition design-response surface methodology (FCCD-RSM) | |
Rezaei et al. | Preparation of milk‐based probiotic lactic acid bacteria biofilms: A new generation of probiotics | |
Murúa‐Pagola et al. | Protective effect of a cross‐linked starch by extrusion on the survival of Bifidobacterium breve ATCC 15700 in yogurt | |
WO2011122934A2 (en) | Bioencapsule and method thereof | |
TURHAN | Optimization of entrapment substances for microencapsulation of Lactobacillus plantarum and Lactobacillus casei shirota against gastric conditions | |
Yin et al. | Construction of double network gel for co-encapsulation of probiotics and capsaicin: Enhanced the physicochemical stability and controlled release | |
Li et al. | Drying of micro-encapsulated lactic acid bacteria—effects of trehalose and immobilization on cell survival and release properties | |
BR102020004392A2 (en) | PROBIOTIC AND SYMBIOTIC POWDER ADDITIVE, BASED ON BIOPOLYMER MICROCAPSULAS, CONTAINING HIGH CONCENTRATION OF LACTOBACILLUS RHAMNOSUS, INCLUDING ITS PROCESS FOR OBTAINING AND USE | |
Khan et al. | Protein-polysaccharide based double network microbeads improves stability of Bifidobacterium infantis ATCC 15697 in a gastro-Intestinal tract model (TIM-1) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180914 |